The higher mortality rate in this study may relate to the clinical profile of participants; specifically, 20% had advanced HIV/AIDS with severe immunodeficiency, as indicated by low CD4 counts, at the time of ART initiation. This evidence concerns the gene CD4 and immunodeficiency disease.